By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DiaKine Therapeutics, Inc. 

Richmond  Virginia    U.S.A.
Phone: n/a Fax:



Company News
Islet Sciences Announces DiaKine Therapeutics, Inc.' Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection 3/30/2012 9:22:49 AM
Islet Sciences Announces Closing of Islet Sciences Acquisition 3/23/2012 6:33:12 AM
Islet Sciences Enters Into Agreement to Acquire DiaKine Therapeutics, Inc. 2/29/2012 2:47:35 PM
DiaKine Therapeutics, Inc. Named a Top Innovator by youngStartup Ventures 12/8/2009 10:06:28 AM
DiaKine Therapeutics, Inc. Diabetes Immune Modulator Drug Set for Human Clinical Trial 5/12/2009 11:04:40 AM
DiaKine Therapeutics, Inc. Drug Improves Type 2 Insulin Action; Reduces Harm of Fat in Preclinical Study 1/22/2009 9:11:35 AM
DiaKine Therapeutics, Inc.'s Lead Compound in Phase 2 Clinical Trial 10/14/2008 11:09:44 AM
DiaKine Therapeutics, Inc. and Kinexum Metabolics, Inc. to Develop Novel Combination Treatment to Type 1 Diabetes 5/6/2008 8:53:01 AM
DiaKine Therapeutics, Inc. Release: Combination Drug Therapy May Hold the Key to Reversing Type 1 Diabetes 4/8/2008 8:42:13 AM
DiaKine Therapeutics, Inc. to Be Awarded Patent for Restoring Insulin Producing Cell Function in Diabetics 4/1/2008 9:01:00 AM